IMI2-PainCare-BioPain-RCT3: a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by electroencephalography (EEG).
André MourauxPetra Bloms-FunkeIrmgard BoeslOmbretta CaspaniSonya C ChapmanGiulia Di StefanoNanna Brix FinnerupLuis Garcia-LarreaMarcus GoetzAnna KostenkoBernhard PelzEsther Pogatzki-ZahnKarin SchubartAlexandre StouffsAndrea TruiniIrene TraceyIñaki F TroconizJohannes Van NielJose Miguel VelaKaty VincentJan VollertVishvarani WanigasekeraMatthias WittayerKeith G PhillipsRolf-Detlef TreedePublished in: Trials (2021)
This trial was registered 25/06/2019 in EudraCT ( 2019%2D%2D001204-37 ).